Please use this identifier to cite or link to this item:
https://hdl.handle.net/2445/185521
Title: | COVID-19 among workers of a comprehensive cancer centre between first and second epidemic waves (2020): a seroprevalence study in Catalonia, Spain |
Author: | Peremiquel Trillas, Paula Saura Lázaro, Anna Benavente Moreno, Yolanda Casabonne, Delphine Loureiro, Eva Cabrera Jaime, Sandra Duran, Angela Garrote, Lidia Brao, Immaculada Trelis, Jordi Galán, Maica Soler, Francesc Julià, Joaquim Cortasa, Dolça Domínguez Luzón, Ma. Ángeles (María Ángeles) Albasanz Puig, Adaia Gudiol González, Carlota Ramírez Tarruella, Dolors Muniesa, Joan Rivas, Juan Pedro Muñoz Montplet, Carles Sedano, Ana Plans, Àngel Calvo Cerrada, Beatriz Calle, Candela Clopés Estela, Ana Carnicer Pont, Dolors Alemany, Laia Fernández Muñoz, Esteve |
Keywords: | Pandèmia de COVID-19, 2020- SARS-CoV-2 Hospitals COVID-19 Pandemic, 2020- SARS-CoV-2 Hospitals |
Issue Date: | 1-Apr-2022 |
Publisher: | BMJ |
Abstract: | Objectives Patients with cancer are at higher risk for severe COVID-19 infection. COVID-19 surveillance of workers in oncological centres is crucial to assess infection burden and prevent transmission. We estimate the SARS-CoV-2 seroprevalence among healthcare workers (HCWs) of a comprehensive cancer centre in Catalonia, Spain, and analyse its association with sociodemographic characteristics, exposure factors and behaviours. Design Cross-sectional study (21 May 2020-26 June 2020). Setting A comprehensive cancer centre (Institut Catala d'Oncologia) in Catalonia, Spain. Participants All HCWs (N=1969) were invited to complete an online self-administered epidemiological survey and provide a blood sample for SARS-CoV-2 antibodies detection. Primary outcome measure Prevalence (%) and 95% CIs of seropositivity together with adjusted prevalence ratios (aPR) and 95% CI were estimated. Results A total of 1266 HCWs filled the survey (participation rate: 64.0%) and 1238 underwent serological testing (97.8%). The median age was 43.7 years (p25-p75: 34.8-51.0 years), 76.0% were female, 52.0% were nursing or medical staff and 79.0% worked on-site during the pandemic period. SARS-CoV-2 seroprevalence was 8.9% (95% CI 7.44% to 10.63%), with no differences by age and sex. No significant differences in terms of seroprevalence were observed between onsite workers and teleworkers. Seropositivity was associated with living with a person with COVID-19 (aPR 3.86, 95% CI 2.49 to 5.98). Among on-site workers, seropositive participants were twofold more likely to be nursing or medical staff. Nursing and medical staff working in a COVID-19 area showed a higher seroprevalence than other staff (aPR 2.45, 95% CI 1.08 to 5.52). Conclusions At the end of the first wave of the pandemic in Spain, SARS-CoV-2 seroprevalence among Institut Catala d'Oncologia HCW was lower than the reported in other Spanish hospitals. The main risk factors were sharing household with infected people and contact with COVID-19 patients and colleagues. Strengthening preventive measures and health education among HCW is fundamental. |
Note: | Reproducció del document publicat a: https://doi.org/10.1136/bmjopen-2021-056637 |
It is part of: | BMJ Open, 2022, vol. 12, num. 4, p. e056637 |
URI: | https://hdl.handle.net/2445/185521 |
Related resource: | https://doi.org/10.1136/bmjopen-2021-056637 |
Appears in Collections: | Articles publicats en revistes (Ciències Clíniques) Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
e056637.full.pdf | 754.69 kB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License